4//SEC Filing
Ospraie Ag Science LLC 4
Accession 0000899243-19-021377
CIK 0001441693other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 5:34 PM ET
Size
12.2 KB
Accession
0000899243-19-021377
Insider Transaction Report
Form 4
Ospraie Ag Science LLC
Director10% OwnerOther
Transactions
- Disposition to Issuer
Warrant
2019-08-06−30,666,667→ 0 totalExercise: $1.00From: 2018-02-05Exp: 2020-12-31→ Common Stock (30,666,667 underlying) - Award
Warrant
2019-08-06+30,666,667→ 30,666,667 totalExercise: $1.00Exp: 2021-12-31→ Common Stock (30,666,667 underlying)
Anderson Dwight
Director10% OwnerOther
Transactions
- Disposition to Issuer
Warrant
2019-08-06−30,666,667→ 0 totalExercise: $1.00From: 2018-02-05Exp: 2020-12-31→ Common Stock (30,666,667 underlying) - Award
Warrant
2019-08-06+30,666,667→ 30,666,667 totalExercise: $1.00Exp: 2021-12-31→ Common Stock (30,666,667 underlying)
Footnotes (3)
- [F1]These securities of Marrone Bio Innovations, Inc. (the "Issuer") are or were held by Ospraie Ag Science LLC ("Ospraie LLC"). Mr. Dwight Anderson ("Mr. Anderson") is the Managing Member of Ospraie LLC and, in such capacity, may be deemed to have voting and dispositive power over the securities held for the account of Ospraie LLC. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any.
- [F2]On August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the "Agreement") pursuant to which the expiration date of the warrants to purchase common stock of the Issuer held by Ospraie LLC was extended to December 31, 2021. In addition, pursuant to the Agreement, the Issuer will have a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of common stock underlying such warrants and new warrants ("New Warrants") to purchase shares of common stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.
- [F3](Continued from footnote 2) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share. The transactions reported herein were approved in advance by the Issuer's Board of Directors.
Issuer
MARRONE BIO INNOVATIONS INC
CIK 0001441693
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001730557
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 5:34 PM ET
- Size
- 12.2 KB